WASHINGTON, Dec. 4, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on protocol VP-VLY-686-3403, which until today limited the protocol to a maximum of 90 doses of...
Hence then, the article about fda lifts partial clinical hold on tradipitant for motion sickness was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness )
Also on site :
- No. 20 Virginia notches first 11-win season by beating 25th-ranked Missouri in the Gator Bowl
- Natural gas line rupture stops traffic on 5 Freeway in Castaic
- SK Telecom Unveils A.X K1, Korea's First 500B-Scale Hyperscale AI Model